Antenatal maternal antidepressants drugs affect Activin A concentrations in maternal blood, in amniotic fluid and in fetal cord blood

References

• Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004;103:698–709.
   PubMed Web of Science ®Google Scholar
• Lattimore KA, Donn SM, Kaciroti N, Kemper AR, Neal CR Jr, Vazquez DM. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol 2005;25:595–604.
   PubMedGoogle Scholar
• Ververs TF, van Wensen K, Freund MW, van der Heide M, Visser GH, Schobben AF, de Jong-van den Berg LT, Egberts AC. Association between antidepressant drug use during pregnancy and child healthcare utilisation. BJOG 2009;116:1568–1577.
   PubMed Web of Science ®Google Scholar
• Austin MP. To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects. Psychol Med 2006;36:1663–1670.
   PubMed Web of Science ®Google Scholar
• Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, Koren G. Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 2004;49:726–735.
   PubMed Web of Science ®Google Scholar
• Costa LG, Steardo L, Cuomo V. Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects. Pharmacol Rev 2004;56:103–147.
   PubMed Web of Science ®Google Scholar
• Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007;356:2675–2683.
   PubMed Web of Science ®Google Scholar
• Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354:579–587.
   PubMed Web of Science ®Google Scholar
• Hemels ME, Einarson A, Koren G, Lanctôt KL, Einarson TR. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 2005;39:803–809.
   PubMed Web of Science ®Google Scholar
• Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005;293:2372–2383.
   PubMed Web of Science ®Google Scholar
• Mulder EJ, Ververs FF, de Heus R, Visser GH. Selective Serotonin Reuptake Inhibitors Affect Neurobehavioral Development in the Human Fetus. Neuropsychopharmacology 2011.
   PubMed Web of Science ®Google Scholar
• Noorlander CW, Ververs FF, Nikkels PG, van Echteld CJ, Visser GH, Smidt MP. Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS ONE 2008;3:e2782.
   PubMed Web of Science ®Google Scholar
• Ververs T, Kaasenbrood H, Visser G, Schobben F, de Jong-van den Berg L, Egberts T. Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol 2006;62:863–870.
   PubMed Web of Science ®Google Scholar
• Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005;365:482–487.
   PubMed Web of Science ®Google Scholar
• Florio P, Gazzolo D, Luisi S, Petraglia F. Activin A in brain injury. Adv Clin Chem 2007;43:117–130.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Abella R, Marinoni E, di Iorio R, Li Volti G, Galvano F, Frigiola A, et al. New markers of neonatal neurology. J Matern Fetal Neonatal Med 2009;22 Suppl 3:57–61.
   PubMed Web of Science ®Google Scholar
• Luisi S, Florio P, Reis FM, Petraglia F. Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol 2001;145:225–236.
   PubMed Web of Science ®Google Scholar
• Florio P, Abella RF, de la Torre T, Giamberti A, Luisi S, Butera G, Cazzaniga A, et al. Perioperative activin A concentrations as a predictive marker of neurologic abnormalities in children after open heart surgery. Clin Chem 2007;53:982–985.
   PubMed Web of Science ®Google Scholar
• Tretter YP, Hertel M, Munz B, ten Bruggencate G, Werner S, Alzheimer C. Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo. Nat Med 2000;6:812–815.
   PubMed Web of Science ®Google Scholar
• Florio P, Frigiola A, Battista R, Abdalla Ael H, Gazzolo D, Galleri L, Pinzauti S, et al. Activin A in asphyxiated full-term newborns with hypoxic ischemic encephalopathy. Front Biosci (Elite Ed) 2010;2:36–42.
   PubMedGoogle Scholar
• Florio P, Luisi S, Moataza B, Torricelli M, Iman I, Hala M, Hanna A, et al. High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy. Clin Chem 2007;53:520–522.
   PubMed Web of Science ®Google Scholar
• Florio P, Luisi S, Bruschettini M, Grutzfeld D, Dobrzanska A, Bruschettini P, Petraglia F, Gazzolo D. Cerebrospinal fluid activin a measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. Clin Chem 2004;50:2386–2389.
   PubMed Web of Science ®Google Scholar
• Duman RS. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 2004;5:11–25.
   PubMed Web of Science ®Google Scholar
• Campbell S, Thoms A. Ultrasound measurement of the fetal head to abdomen circumference ratio in the assessment of growth retardation. Br J Obstet Gynaecol 1977;84:165–174.
   PubMedGoogle Scholar
• Florio P, Abella R, Marinoni E, Di Iorio R, Li Volti G, Galvano F, Pongiglione G, et al. Biochemical markers of perinatal brain damage. Front Biosci (Schol Ed) 2010;2:47–72.
   PubMedGoogle Scholar
• Florio P, Calonaci G, Luisi S, Severi FM, Ignacchiti E, Palumbo M, Bocchi C, Petraglia F. Inhibin A, inhibin B and activin A concentrations in umbilical cord artery and vein. Gynecol Endocrinol 2003;17:181–185.
   PubMed Web of Science ®Google Scholar
• Florio P, Luisi S, Ciarmela P, Severi FM, Bocchi C, Petraglia F. Inhibins and activins in pregnancy. Mol Cell Endocrinol 2004;225:93–100.
   PubMed Web of Science ®Google Scholar
• Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999;46:1181–1191.
   PubMed Web of Science ®Google Scholar
• Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 2001;35:5–49.
   PubMedGoogle Scholar
• Petraglia F, Gomez R, Luisi S, Florio P, Tolosa JE, Stomati M, Romero R. Increased midtrimester amniotic fluid activin A: a risk factor for subsequent fetal death. Am J Obstet Gynecol 1999;180:194–197.
   PubMed Web of Science ®Google Scholar
• Florio P, Perrone S, Luisi S, Vezzosi P, Longini M, Marzocchi B, Petraglia F, Buonocore G. Increased plasma concentrations of activin a predict intraventricular hemorrhage in preterm newborns. Clin Chem 2006;52:1516–1521.
   PubMed Web of Science ®Google Scholar